GLYC Old Analysis
| GLYCDelisted Stock | USD 0.16 0.01 5.88% |
GLYC Old is overvalued with Real Value of 0.15 and Hype Value of 0.15. The main objective of GLYC Old delisted stock analysis is to determine its intrinsic value, which is an estimate of what GLYC Old is worth, separate from its market price. There are two main types of GLYC Old's stock analysis: fundamental analysis and technical analysis.
The GLYC Old stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GLYC Old's ongoing operational relationships across important fundamental and technical indicators.
GLYC |
GLYC Stock Analysis Notes
About 48.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 46.0. GLYC Old had not issued any dividends in recent years. GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people. To learn more about GLYC Old call Rachel King at 240 243 1201 or check out https://www.glycomimetics.com.GLYC Old Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GLYC Old's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GLYC Old or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| GLYC Old is now traded under the symbol CBIO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| GLYC Old is not yet fully synchronised with the market data | |
| GLYC Old is way too risky over 90 days horizon | |
| GLYC Old has some characteristics of a very speculative penny stock | |
| GLYC Old appears to be risky and price may revert if volatility continues | |
| GLYC Old has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (37.88 M) with profit before overhead, payroll, taxes, and interest of 10 K. | |
| GLYC Old currently holds about 60.24 M in cash with (31.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
GLYC Old Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GLYC Old previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
GLYC Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.13 M.GLYC Old Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GLYC Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on GLYC Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GLYC Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GLYC Old Predictive Daily Indicators
GLYC Old intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GLYC Old stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About GLYC Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how GLYC Old prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GLYC shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as GLYC Old. By using and applying GLYC Stock analysis, traders can create a robust methodology for identifying GLYC entry and exit points for their positions.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland. Glycomimetics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding GLYC Old to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in GLYC Stock
If you are still planning to invest in GLYC Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GLYC Old's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |